Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	56.98B
Revenue (ttm)	19.98B
Net Income (ttm)	2.49B
Shares Out	1.59B
EPS (ttm)	1.57
PE Ratio	22.84
Forward PE	16.32
Dividend	1.01 (2.88%)
Ex-Dividend Date	Jun 13, 2025

Volume	14,894,067
Average Volume	17,057,850
Open	34.64
Previous Close	34.98
Day's Range	34.64 - 36.08
52-Week Range	25.72 - 40.80
Beta	-0.01
RSI	49.38
Earnings Date	Aug 29, 2025

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sic...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 21,864
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2024, SHE:002422's revenue was 21.81 billion, an increase of 1.67% compared to the previous year's 21.45 billion. Earnings were 2.94 billion, an increase of 19.53%.